Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Palliative Medicine in Practice
MENU
Shortcuts Submit an article Author Guidelines Reviewers 2023 Editorial Team Focus and Scope

open access

Vol 13, No 4 (2019)
Review paper
Published online: 2020-01-03
View PDF Download PDF file
Get Citation

Opioids in clinical practice

Iwona Zaporowska-Stachowiak12, Mary-Tiffany Adannia Oduah3, Magdalena Celichowska4, Gabriela Dziuba4, Anna Mikołajczak4, Maria Perlińska4, Martyna Woźniak4, Lidia Gorzelinska2, Maciej Sopata2
DOI: 10.5603/PMPI.2019.0024
·
Palliat Med Pract 2019;13(4):221-228.
Affiliations
  1. Chair and Department of Palliative Medicine, Poznan University of Medical Science, Poznan, Poland
  2. Palliative Medicine In-Patient Unit, University Hospital of Lord’s Transfiguration, Poznan University of Medical Sciences, Os. Rusa 55, 61-245 Poznan, Poland
  3. English Students’ Research Association, Poznan University of Medical Sciences, Jackowskiego 41, 60-512 Poznan, Poland
  4. Students' Scientific Society, Poznan University of Medical Sciences, Poznan, Poland

open access

Vol 13, No 4 (2019)
Review paper
Published online: 2020-01-03

Abstract

The treatment of pain improves quality of life. Opioids are commonly prescribed painkillers. The side effects
of opioids depend on the route of administration, dosage, drug metabolism, comorbid diseases and the
patient’s general condition. Despite many beneficial effects, opioids can lead to increased mortality in heart
failure, myocardial infarction, pulmonary oedema, and COPD. This article reviews specific uses of opioid
medications. Opioids induce immunosuppression, and may undergo drug-drug interactions, especially
during polytherapy or polypragmasia.

Abstract

The treatment of pain improves quality of life. Opioids are commonly prescribed painkillers. The side effects
of opioids depend on the route of administration, dosage, drug metabolism, comorbid diseases and the
patient’s general condition. Despite many beneficial effects, opioids can lead to increased mortality in heart
failure, myocardial infarction, pulmonary oedema, and COPD. This article reviews specific uses of opioid
medications. Opioids induce immunosuppression, and may undergo drug-drug interactions, especially
during polytherapy or polypragmasia.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

adverse effects, analgesia, morphine, opioids, pain management

About this article
Title

Opioids in clinical practice

Journal

Palliative Medicine in Practice

Issue

Vol 13, No 4 (2019)

Article type

Review paper

Pages

221-228

Published online

2020-01-03

Page views

1293

Article views/downloads

968

DOI

10.5603/PMPI.2019.0024

Bibliographic record

Palliat Med Pract 2019;13(4):221-228.

Keywords

adverse effects
analgesia
morphine
opioids
pain management

Authors

Iwona Zaporowska-Stachowiak
Mary-Tiffany Adannia Oduah
Magdalena Celichowska
Gabriela Dziuba
Anna Mikołajczak
Maria Perlińska
Martyna Woźniak
Lidia Gorzelinska
Maciej Sopata

References (53)
  1. Katzung BG. Basic and Clinical Pharmacology. McGraw-Hill Medical 2012.
  2. Drug Actions: Basic Principles and Therapeutic Aspects, Mutschler. Hartmut .
  3. Liman AG, Gauthier ME. Pharmacology of oioid drugs (basic rinciles). In: Portenoy RK, Bruera E. ed. Toics in alliative care. Oxford University Press, New York 1997.
  4. Coppes OJ, Sang CN. Indications for Opioid Antagonists. Curr Pain Headache Rep. 2017; 21(6): 30.
    CrossRefPubMed
  5. Leś J, Grzesiak J, Sokół–Kobielska E. Pain therapy Part V. Cancer pain article–4a89b590-2c7c-437d-8951-70aeaa89b807.
  6. Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017; 7: CD012592.
    CrossRefPubMed
  7. Jamison RN, Mao J. Opioid Analgesics. Mayo Clin Proc. 2015; 90(7): 957–968.
    CrossRefPubMed
  8. Gommers D, Bakker J. Medications for analgesia and sedation in the intensive care unit: an overview. Crit Care. 2008; 12 Suppl 3: S4.
    CrossRefPubMed
  9. Rubio-Haro R, Morales-Sarabia J, Ferrer-Gomez C, et al. Regional analgesia techniques for pain management in patients admitted to the intensive care unit. Minerva Anestesiol. 2019; 85(10): 1118–1128.
    CrossRefPubMed
  10. Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002; 57(11): 939–944.
    CrossRefPubMed
  11. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003; 327(7414): 523–528.
    CrossRefPubMed
  12. Senderovich H, Yendamuri A. Management of Breathlessness in Palliative Care: Inhalers and Dyspnea-A Literature Review. Rambam Maimonides Med J. 2019; 10(1).
    CrossRefPubMed
  13. Cohen B, Preuss CV. Opioid Analgesics [Updated 2019 Apr 3]. .
    PubMed
  14. Leppert W, Krajnik M, Wordliczek J. Delivery systems of opioid analgesics for pain relief: a review. Curr Pharm Des. 2013; 19(41): 7271–7293.
    CrossRefPubMed
  15. Cohen B, Preuss CV. Opioid Analgesics. [Updated 2019 Apr 3]. .
    PubMed
  16. Miyazaki T, Satou S, Ohno T, et al. Topical morphine gel for pain management in head and neck cancer patients. Auris Nasus Larynx. 2014; 41(5): 496–498.
    CrossRefPubMed
  17. Giannopoulos G, Deftereos S, Kolokathis F, et al. P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison? Circ Cardiovasc Interv. 2016; 9(9).
    CrossRefPubMed
  18. Anderson IB, Kearney TE. Use of methadone. West J Med. 2000; 172(1): 43–46.
    CrossRefPubMed
  19. Cavallari LH, Jeong H, Bress A. Role of cytochrome P450 genotype in the steps toward personalized drug therapy. Pharmgenomics Pers Med. 2011; 4: 123–136.
    CrossRefPubMed
  20. Dickman A. Drugs in Palliative Care. Oxford Medicine Online. 2012.
    CrossRef
  21. Jamison RN, Mao J. Opioid Analgesics. Mayo Clin Proc. 2015; 90(7): 957–968.
    CrossRefPubMed
  22. Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J. 2008; 10(4): 537–551.
    CrossRefPubMed
  23. Meine TJ, Roe MT, Chen AY, et al. CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149(6): 1043–1049.
    CrossRefPubMed
  24. Kao D, Bucher Bartelson B, Khatri V, et al. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data. Ann Intern Med. 2013; 158(10): 735–740.
    CrossRefPubMed
  25. Brown R, Kraus C, Fleming M, et al. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004; 80(949): 654–659.
    CrossRefPubMed
  26. Mattia C. Coluzzi, F. A look inside the association codeine–paracetamol: clinical pharmacology supports analgesic efficacy. Eur Rev Medical Pharmacological Sciences 2015; 19: 507–516. PMID. ; 25720726.
  27. Leppert W. Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab. 2010; 11(6): 494–506.
    CrossRefPubMed
  28. Leppert W, Majkowicz M. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract. 2010; 64(12): 1681–1687.
    CrossRefPubMed
  29. Robertson JR, Raab GM, Bruce M, et al. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial. Addiction. 2006; 101(12): 1752–1759.
    CrossRefPubMed
  30. Leppert W, Majkowicz M. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract. 2010; 64(12): 1681–1687.
    CrossRefPubMed
  31. Robertson JR, Raab GM, Bruce M, et al. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial. Addiction. 2006; 101(12): 1752–1759.
    CrossRefPubMed
  32. Edwards JE, McQuay HJ, Moore RA. Single dose dihydrocodeine for acute postoperative pain. Cochrane Database Syst Rev. 2000(4): CD002760.
    CrossRefPubMed
  33. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl): 238S–249S.
    CrossRefPubMed
  34. Finnerup N, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology. 2015; 14(2): 162–173.
    CrossRef
  35. de Alencar Neto JN. Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review. Cureus. 2018; 10(1): e2114.
    CrossRefPubMed
  36. Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency Medicine Journal. 2008; 25(4): 205–209.
    CrossRef
  37. Miró Ò, Gil V, Peacock WF. Morphine in acute heart failure: good in relieving symptoms, bad in improving outcomes. J Thorac Dis. 2017; 9(9): E871–E874.
    CrossRefPubMed
  38. Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not analgesia. Br J Anaesth. 2006; 96: 627–632.
    CrossRefPubMed
  39. Bonin M, Mewton N, Roubille F, et al. CIRCUS Study Investigators. Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2018; 7(4).
    CrossRefPubMed
  40. Kubica J, Adamski P, Ostrowska M, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J. 2016; 37(3): 245–252.
    CrossRef
  41. Meine TJ, Roe MT, Chen AY, et al. CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149(6): 1043–1049.
    CrossRefPubMed
  42. Hobl EL, Stimpfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2014; 63(7): 630–635.
    CrossRefPubMed
  43. Iakobishvili Z, Cohen E, Garty M, et al. Heart Failure Survey in Isarel (HFSIS) Investigators. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care. 2011; 13(2): 76–80.
    CrossRefPubMed
  44. Dominguez-Rodriguez A, Abreu-Gonzalez P. A critical appraisal of the morphine in the acute pulmonary edema: real or real uncertain? J Thorac Dis. 2017; 9(7): 1802–1805.
    CrossRefPubMed
  45. Sosnowski MA. Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema. Emerg Med Australas. 2008; 20(5): 384–390.
    CrossRefPubMed
  46. Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol. 2016; 81(1): 161–170.
    CrossRefPubMed
  47. Abdallah SJ, Wilkinson-Maitland C, Saad N, et al. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J. 2017; 50(4).
    CrossRefPubMed
  48. Caraceni A, Davies A, Poulain P, et al. Lancet Oncol. 2012; 13: 58–68.
  49. Corli O, Forliani I, Roberto A, et al. Ann Oncol. 2016; 27: 1107–1115.
  50. Rigamonti CI, Santini D, Maranzano E, et al. Ann Oncol. 2012; 23(Suppl 7): 139–154.
  51. Misiołek H, Zajączkowska R, Daszkiewicz A. Postoperative pain management — 2018. Anaesthesiol Intensive Ther. 2018.
  52. Smith J, Owen E, Earis J, et al. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006; 117(4): 831–835.
    CrossRefPubMed
  53. Bolser DC, Davenport PW. Codeine and cough: an ineffective gold standard. Curr Opin Allergy Clin Immunol. 2007; 7(1): 32–36.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl